Clinical Trial Update: NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

The update covers a Phase 1/2 study of NovoTTF-100L in combination with pemetrexed for advanced non-small cell lung cancer, sponsored by NovoCure Ltd; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• NovoTTF-100L (Tumor Treating Fields)

Snippet

Sponsor: NovoCure Ltd. | Conditions: Non-small Cell Lung Cancer, NSCLC | Phase 1, Phase 2 | Status: COMPLETED